Showing results (191-200 of 486) with videos related to

Sort By:
Pageof 49
Annals of Hematology|March 28, 2025
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndromeGuillermo Garcia-Manero, Manila Gaddh, Uwe Platzbecker, et al.
Leukemia|March 22, 2024
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic nicheSusann Winter, Katharina S Götze, Judith S Hecker, et al.
Plos Genetics|March 19, 2016
MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETONicole Kohrs, Stephan Kolodziej, Olga N Kuvardina, et al.
American Journal of Hematology|April 28, 2009
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogeneticsCrawford J Strunk, Uwe Platzbecker, Christian Thiede, et al.
JCO Oncology Practice|January 11, 2024
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care SystemFrancesco Sparano, Johannes M Giesinger, Gianluca Gaidano, et al.
American Journal of Hematology|September 8, 2011
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemiaDjordje Atanackovic, Tim Luetkens, Benjamin Kloth, et al.
Cytotherapy|January 10, 2015
Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host diseaseAnke Theil, Sebastian Tuve, Uta Oelschlägel, et al.
European Journal of Haematology|September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patientsSabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Frontiers in Oncology|January 24, 2022
Case Report: Large Granular Lymphocyte Leukemia (LGLL)-A Case Series of Challenging PresentationsNatali Pflug, Annika Littauer, David Beverungen, et al.
Pageof 49